Lukas Kovar - Search Results

Year	Number of Results
2020	4
2021	2
2022	2
2024	0

1

A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications.

Cicali EJ, Smith DM, Duong BQ, Kovar LG, Cavallari LH, Johnson JA. Cicali EJ, et al. Among authors: kovar lg. Clin Pharmacol Ther. 2020 Jul;108(1):116-125. doi: 10.1002/cpt.1768. Epub 2020 Feb 13. Clin Pharmacol Ther. 2020. PMID: 31910286 Free PMC article. Review.

2

Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies.

Kovar L, Selzer D, Britz H, Benowitz N, St Helen G, Kohl Y, Bals R, Lehr T. Kovar L, et al. Clin Pharmacokinet. 2020 Sep;59(9):1119-1134. doi: 10.1007/s40262-020-00880-4. Clin Pharmacokinet. 2020. PMID: 32166575 Free PMC article.

3

Prediction of Drug-Drug-Gene Interaction Scenarios of (E)-Clomiphene and Its Metabolites Using Physiologically Based Pharmacokinetic Modeling.

Kovar C, Kovar L, Rüdesheim S, Selzer D, Ganchev B, Kröner P, Igel S, Kerb R, Schaeffeler E, Mürdter TE, Schwab M, Lehr T. Kovar C, et al. Among authors: kovar l. Pharmaceutics. 2022 Nov 25;14(12):2604. doi: 10.3390/pharmaceutics14122604. Pharmaceutics. 2022. PMID: 36559098 Free PMC article.

4

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates.

Kovar L, Schräpel C, Selzer D, Kohl Y, Bals R, Schwab M, Lehr T. Kovar L, et al. Pharmaceutics. 2020 Jun 23;12(6):578. doi: 10.3390/pharmaceutics12060578. Pharmaceutics. 2020. PMID: 32585880 Free PMC article.

5

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients.

Kovar L, Weber A, Zemlin M, Kohl Y, Bals R, Meibohm B, Selzer D, Lehr T. Kovar L, et al. Pharmaceutics. 2020 Sep 23;12(10):908. doi: 10.3390/pharmaceutics12100908. Pharmaceutics. 2020. PMID: 32977559 Free PMC article.

6

Influence of Physicochemical Characteristics and Stability of Gold and Silver Nanoparticles on Biological Effects and Translocation across an Intestinal Barrier-A Case Study from In Vitro to In Silico.

Kohl Y, Hesler M, Drexel R, Kovar L, Dähnhardt-Pfeiffer S, Selzer D, Wagner S, Lehr T, von Briesen H, Meier F. Kohl Y, et al. Among authors: kovar l. Nanomaterials (Basel). 2021 May 21;11(6):1358. doi: 10.3390/nano11061358. Nanomaterials (Basel). 2021. PMID: 34063963 Free PMC article.

7

In Vitro-In Silico Modeling of Caffeine and Diclofenac Permeation in Static and Fluidic Systems with a 16HBE Lung Cell Barrier.

Kovar L, Wien L, Selzer D, Kohl Y, Bals R, Lehr T. Kovar L, et al. Pharmaceuticals (Basel). 2022 Feb 18;15(2):250. doi: 10.3390/ph15020250. Pharmaceuticals (Basel). 2022. PMID: 35215362 Free PMC article.

8

External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease.

Schräpel C, Kovar L, Selzer D, Hofmann U, Tran F, Reinisch W, Schwab M, Lehr T. Schräpel C, et al. Among authors: kovar l. Pharmaceutics. 2021 Aug 31;13(9):1368. doi: 10.3390/pharmaceutics13091368. Pharmaceutics. 2021. PMID: 34575443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year